Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -50.85x is 54% above its 5-year average of -109.89x, near the high end of its 5-year range (-407.07x–-1.76x).
71.29% above its 12-month average of -177.10x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -18.74x.
INTEREST COVERAGE RATIO
-50.85x
INTEREST COVERAGE RATIO AVG TTM
-177.10x
INTEREST COVERAGE RATIO AVG 3Y
-92.62x
INTEREST COVERAGE RATIO AVG 5Y
-109.89x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+71.29%
CURRENT VS 3Y AVG
+45.10%
CURRENT VS 5Y AVG
+53.73%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.37x
median of 368 covered companies
CURRENT VS SECTOR MEDIAN
-1064.95%
vs the sector median at left
TuHURA Biosciences, Inc.
Market Cap
$120.24M
Interest Coverage Ratio
-50.85x
TTM Avg
-177.10x
3Y Avg
-92.62x
5Y Avg
-109.89x
Market Cap
$121.25M
Interest Coverage Ratio
-41.14x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$116.83M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$116.57M
Interest Coverage Ratio
-280.53x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$116.54M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$114.79M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| TuHURA Biosciences, Inc. (HURA) | $120.24M | -50.85x | -177.10x | -92.62x | -109.89x |
| enGene Holdings Inc. (ENGN)vs › | $121.25M | -41.14x | N/A | N/A | N/A |
| Cibus, Inc. (CBUS)vs › | $123.66M | -1.90x | N/A | N/A | N/A |
| LENZ Therapeutics, Inc. (LENZ)vs › | $116.83M | N/A | N/A | N/A | N/A |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $116.57M | -280.53x | N/A | N/A | N/A |
| Entera Bio Ltd. (ENTX)vs › | $124.95M | N/A | N/A | N/A | N/A |
| Caribou Biosciences, Inc. (CRBU)vs › | $116.54M | N/A | N/A | N/A | N/A |
| Genelux Corporation (GNLX)vs › | $114.79M | N/A | N/A | N/A | N/A |
| MaxCyte, Inc. (MXCT)vs › | $114.62M | N/A | N/A | N/A | N/A |
| Coya Therapeutics, Inc. (COYA)vs › | $112.36M | N/A | N/A | N/A | N/A |
Interest Coverage
-50.9x
Debt/Equity
0.02
Current Ratio
0.18
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -18.74x |
| 2026-03-31 | -269.17x |
| 2025-12-31 | -13.43x |
| 2025-09-30 | -407.07x |
| 2024-12-31 | -10.89x |
| 2024-09-30 | -1.86x |
| 2024-06-30 | -1.76x |
| 2024-03-31 | -18.05x |
| 2021-06-30 | -248.04x |
| 2021-03-31 | -220.17x |
| 2020-12-31 | -162.97x |
| 2020-09-30 | -82.60x |
